Vimpat

In the US, Vimpat (lacosamide systemic) is a member of the drug class miscellaneous anticonvulsants and is used to treat Seizures.

US matches:

• Vimpat


• Vimpat Tablets


• Vimpat Intravenous

UK matches:

• Vimpat 50 mg, 100 mg, 150 mg & 200 mg film-coated tablets, 15 mg/ml syrup and 10 mg/ml solution for infusion (SPC)

Ingredient matches for Vimpat

Lacosamide

Lacosamide is reported as an ingredient of Vimpat in the following countries:

• Australia


• Austria


• France


• Germany


• Spain


• Sweden


• Switzerland


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Medacinase

Medacinase may be available in the countries listed below.

Ingredient matches for Medacinase

Urokinase

Urokinase is reported as an ingredient of Medacinase in the following countries:

• Netherlands

International Drug Name Search

Salipax

Salipax may be available in the countries listed below.

Ingredient matches for Salipax

Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Salipax in the following countries:

• Malta


• Poland


• Slovenia

International Drug Name Search

Medipam

Medipam may be available in the countries listed below.

Ingredient matches for Medipam

Diazepam

Diazepam is reported as an ingredient of Medipam in the following countries:

• Finland

International Drug Name Search